856 related articles for article (PubMed ID: 23341536)
1. Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season.
Bateman AC; Kieke BA; Irving SA; Meece JK; Shay DK; Belongia EA
J Infect Dis; 2013 Apr; 207(8):1262-9. PubMed ID: 23341536
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of 1 dose of influenza A (H1N1) 2009 monovalent vaccines in preventing reverse-transcription polymerase chain reaction-confirmed H1N1 infection among school-aged children in maine.
Uzicanin A; Thompson M; Smith P; Chaves SS; Foster L; Dube N; Graitcer S; Jackson R; Ferdinands J; Gargiullo P; Mills D; Monto AS; Shay DK;
J Infect Dis; 2012 Oct; 206(7):1059-68. PubMed ID: 22850120
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.
Belongia EA; Kieke BA; Donahue JG; Greenlee RT; Balish A; Foust A; Lindstrom S; Shay DK;
J Infect Dis; 2009 Jan; 199(2):159-67. PubMed ID: 19086915
[TBL] [Abstract][Full Text] [Related]
4. Uptake and effectiveness of monovalent influenza A (H1N1) pandemic 2009 vaccine among healthcare personnel in Kenya, 2010.
Njuguna H; Ahmed J; Oria PA; Arunga G; Williamson J; Kosgey A; Muthoka P; Mott JA; Breiman RF; Katz MA
Vaccine; 2013 Sep; 31(41):4662-7. PubMed ID: 23859843
[TBL] [Abstract][Full Text] [Related]
5. Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children.
Örtqvist Å; Bennet R; Hamrin J; Rinder MR; Lindblad H; Öhd JN; Eriksson M
Vaccine; 2015 May; 33(22):2558-61. PubMed ID: 25869891
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study.
Mahmud S; Hammond G; Elliott L; Hilderman T; Kurbis C; Caetano P; Van Caeseele P; Kettner J; Dawood M
Vaccine; 2011 Oct; 29(45):7975-81. PubMed ID: 21884747
[TBL] [Abstract][Full Text] [Related]
7. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.
Skowronski DM; Janjua NZ; Sabaiduc S; De Serres G; Winter AL; Gubbay JB; Dickinson JA; Fonseca K; Charest H; Bastien N; Li Y; Kwindt TL; Mahmud SM; Van Caeseele P; Krajden M; Petric M
J Infect Dis; 2014 Jul; 210(1):126-37. PubMed ID: 24446529
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of the pandemic influenza A/H1N1 2009 monovalent vaccine in Korea.
Song JY; Cheong HJ; Heo JY; Noh JY; Choi WS; Park DW; Lee J; Jeong HW; Kee SY; Kim WJ
Vaccine; 2011 Feb; 29(7):1395-8. PubMed ID: 21199701
[TBL] [Abstract][Full Text] [Related]
9. Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.
Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay JB; Drews SJ; Martineau C; Charest H; Krajden M; Bastien N; Li Y
J Infect Dis; 2017 Dec; 216(12):1487-1500. PubMed ID: 29029166
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study.
Castilla J; Morán J; Martínez-Artola V; Fernández-Alonso M; Guevara M; Cenoz MG; Reina G; Alvarez N; Arriazu M; Elía F; Salcedo E; Barricarte A;
Vaccine; 2011 Aug; 29(35):5919-24. PubMed ID: 21723358
[TBL] [Abstract][Full Text] [Related]
11. Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States.
Gaglani M; Pruszynski J; Murthy K; Clipper L; Robertson A; Reis M; Chung JR; Piedra PA; Avadhanula V; Nowalk MP; Zimmerman RK; Jackson ML; Jackson LA; Petrie JG; Ohmit SE; Monto AS; McLean HQ; Belongia EA; Fry AM; Flannery B
J Infect Dis; 2016 May; 213(10):1546-56. PubMed ID: 26743842
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of trivalent seasonal and monovalent influenza A(H1N1)2009 vaccines in population with major chronic conditions of Navarre, Spain: 2010/11 mid-season analysis.
Castilla J; Moran J; Martinez-Artola V; Reina G; Martinez-Baz I; Garcia Cenoz M; Alvarez N; Irisarri F; Arriazu M; Elia F; Salcedo E
Euro Surveill; 2011 Feb; 16(7):. PubMed ID: 21345321
[TBL] [Abstract][Full Text] [Related]
13. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y
J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of trivalent and pandemic influenza vaccines in England and Wales 2008-2010: results from a cohort study in general practice.
Hardelid P; Fleming DM; Andrews N; Barley M; Durnall H; Mangtani P; Pebody R
Vaccine; 2012 Feb; 30(7):1371-8. PubMed ID: 22178524
[TBL] [Abstract][Full Text] [Related]
15. Association between seasonal influenza vaccination in 2008-2009 and pandemic influenza A (H1N1) 2009 infection among school students from Kobe, Japan, April-June 2009.
Tsuchihashi Y; Sunagawa T; Yahata Y; Takahashi H; Toyokawa T; Odaira F; Ohyama T; Taniguchi K; Okabe N
Clin Infect Dis; 2012 Feb; 54(3):381-3. PubMed ID: 22100572
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11.
Pebody R; Hardelid P; Fleming D; McMenamin J; Andrews N; Robertson C; Thomas D; Sebastianpillai P; Ellis J; Carman W; Wreghitt T; Zambon M; Watson J
Euro Surveill; 2011 Feb; 16(6):. PubMed ID: 21329644
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 mid-season results.
Pebody R; Warburton F; Ellis J; Andrews N; Potts A; Cottrell S; Johnston J; Reynolds A; Gunson R; Thompson C; Galiano M; Robertson C; Mullett D; Gallagher N; Sinnathamby M; Yonova I; Moore C; McMenamin J; de Lusignan S; Zambon M
Euro Surveill; 2016; 21(13):. PubMed ID: 27074651
[TBL] [Abstract][Full Text] [Related]
18. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.
Kissling E; Valenciano M; Buchholz U; Larrauri A; Cohen JM; Nunes B; Rogalska J; Pitigoi D; Paradowska-Stankiewicz I; Reuss A; Jiménez-Jorge S; Daviaud I; Guiomar R; O'Donnell J; Necula G; Głuchowska M; Moren A
Euro Surveill; 2014 Feb; 19(6):. PubMed ID: 24556348
[TBL] [Abstract][Full Text] [Related]
19. Influenza vaccine effectiveness against medically-attended influenza illness during the 2012-2013 season in Beijing, China.
Yang P; Thompson MG; Ma C; Shi W; Wu S; Zhang D; Wang Q
Vaccine; 2014 Sep; 32(41):5285-9. PubMed ID: 25092635
[TBL] [Abstract][Full Text] [Related]
20. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
